BSECompany Update6 Oct 2026 · 6 Oct 2026, 02:30 pm
Submission of Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018.
Novelix Pharmaceuticals Ltd · 536565
✦ AI Summary
Novelix Pharmaceuticals Ltd has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th September, 2026, confirming the dematerialization of securities and updating the records of the company.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Novelix Pharmaceuticals Ltd - 536565 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Attachments (1)
📄pdf
Download →
446a887c-7ead-4eef-b47e-30d5c8fa18ed.pdf
View document text
Novelix Pharmaceuticals limited
(Formerly TRIMURTHI LIMITED) CIN: L67120TG1994PLC018956
(NOVELIX | 536565 | INE314I01036)
Date: 06th October, 2026
The Deputy Manager
(Department of Corporate Services),
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Fort,
Mumbai-400001.
Sub.: Certificate under Regulation 74(5) of SEBI (Depositories and Participants)
Regulations, 2018.
Ref.: Scrip Id: NOVELIX
Scrip Code: 536565
Respected Sir/Madam,
With reference to above, we are enclosing herewith the Certificate from our Registrar and Share
Transfer Agent (R&T Agent) – i.e. M/s. Venture Capital and Corporate Investments Private
Limited under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for
Novelix Pharmaceuticals Limited for the quarter ended 30th September, 2026.
Please take the same on your records.
Thanking you,
Yours Faithfully,
For Novelix Pharmaceuticals Limited
Venkateshwarlu Pulluru
(Whole-time director)
DIN: 02076871
Novelix Pharmaceuticals limited
(Formerly Known as TRIMURTHI LIMITED)
H No: 3-6-237/610, Flat No: 610, 6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat
Nagar, Hyderabad, Telangana- 500029 Ph No: +91 8977631044 Email: novelixpharmaceuticals@gmail.com
www.novelixpharma.com
Date: 05-10-2026
THE COMPANY SECRETARY
NOVELIX PHARMACEUTICALS LIMITED
REGD. OFF: # 3-6-237/610, FLAT NO: 610, 6TH FLOOR
LINGAPUR LA BUILDERS, ALSO KNOWN AS AMRUTHA ESTATES
HIMAYAT NAGAR, HYDERABAD, TELANGANA- 500029
Dear Sir/Madam,
Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations,
2018 for the quarter ended 30.09.2026
Ref: Security Code – 536565 ISIN: INE314I01036
We hereby certify that the securities received for dematerialisation have been mutilated and
cancelled after due verification and the name of the depositories (National Securities Depository
Limited (NSDL) and Central Depository Services (India) Limited (CDSL) has been updated in
the records of company as the registered owner within 15 days of receipt of valid DRF & Share
certificate of said company and the details of securities are furnished to the stock exchange(s).
We request you to take this information on record and to inform Depositories(s) and Stock
Exchange(s) wherever your securities are listed accordingly.
Thanking you,
Yours faithfully,
for Venture Capital and Corporate Investments Private Limited.
Authorised Signatory.
Note : You are requested to inform Depositories(s) and Stock Exchange(s) wherever your security is
listed accordingly.